Chemical Compound

3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide; Ivacaftor; Kalydeco; N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide; VX 770

CAS Registry Number 873054-44-5
3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide; Ivacaftor; Kalydeco; N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide; VX 770 结构式
Primary record

3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide; Ivacaftor; Kalydeco; N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide; VX 770

库存
7,432 克
纯度
98.7 %
CAS
873054-44-5

化合物标识与属性

CAS
873054-44-5
PubChem CID
16220172
SMILES
CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
Canonical SMILES
CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O

名称与同义词

  • Ivacaftor
  • Kalydeco
  • 873054-44-5
  • Ivacaftor (VX-770)
  • VX-770
  • ivacaftorum
  • Ivacaftor-d18
  • Deutivacaftor
  • Kalydeco (TN)
  • Ivacaftor [USAN]
  • Ivacaftor Impurity
  • Ivacaftor D18
  • Ivacaftor-[d18]
  • Ivacaftor [USAN:INN]
  • N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
  • Tube715
  • IVACAFTOR [INN]
  • RefChem:58494
  • IVACAFTOR [MI]
  • Ivacaftor (USAN/INN)
  • VX 770
  • VX-770 - Ivacaftor
  • 1Y740ILL1Z
  • IVACAFTOR [VANDF]
  • UNII-1Y740ILL1Z
  • VX770
  • MFCD17171361
  • CHEBI:66901
  • D0W7WC
  • Ivacaftor - 25MG 25mg
  • IVACAFTOR [WHO-DD]
  • C24H28N2O3
  • Ivacaftor (4-tertbutyl-d9)
  • cc-231
  • MLS006011119
  • SCHEMBL351373
  • SCHEMBL417309
  • DTXSID00236281
  • ORKAMBI COMPONENT IVACAFTOR
  • SYMKEVI COMPONENT IVACAFTOR
  • GTPL4342
  • orb1305294
  • QUI135
  • TRIKAFTA COMPONENT IVACAFTOR
  • IVACAFTOR [ORANGE BOOK]
  • VX-770, Ivacaftor, Kalydeco
  • CHEMBL2010601
  • SCHEMBL29357389
  • SCHEMBL29379239
  • DTXCID00158772
  • EX-A441
  • QCR-155
  • R07AX02
  • N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
  • PURKAOJPTOLRMP-UHFFFAOYSA-N
  • s1144
  • BCPP000199
  • HMS3654E10
  • HMS3744K05
  • HMS5079A11
  • AOB31714
  • BCP19794
  • NGC43107
  • ABP000259
  • BDBM50032693
  • EBC-11412
  • VX-770/VX770
  • ZINC52509463
  • Ivacaftor (4-tertbutyl-d9) (Major)
  • AKOS015994762
  • AKOS032950001
  • C24-H28-N2-O3
  • Elexacaftor, Tezacaftor, and Ivacaftor
  • BCP9000799
  • BLP-012401
  • CCG-268562
  • CS-0497
  • DB08820
  • EX-7211
  • LE-0002
  • SB16815
  • KS-0000063W
  • compound 48 [PMID: 25441013]
  • NCGC00242480-01
  • NCGC00242480-03
  • 4CA-0661
  • AC-28324
  • AK170457
  • AN-16981
  • BC660099
  • CID:16220172
  • DA-54489
  • FI143182
  • HY-13017
  • SC-95534
  • SMR004702900
  • SY067891
  • SID:135653729
  • 1413431-05-6
  • AB0008116
  • AB2000007
  • N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
  • A5047
  • FT-0696681
  • NS00009974
  • SW219620-1
  • X7565
  • EC-000.2478
  • J3.163.539J
  • A10985
  • A25626
  • D09916
  • W-5681
  • AB01565806_02
  • EN300-7400944
  • C545203
  • F468426
  • Q6095693
  • 3-Quinolinecarboxamide, N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-
  • BRD-K52818472-001-02-2
  • VX770, VX 770, Ivacaftor, 873054-44-5
  • Z2146566713
  • 3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-
  • B0084-286767
  • CTP-656; CTP-656; CTP-656; d9-ivacaftor;VX-561
  • N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
  • 1413431-07-8
  • Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
  • N-(2,4-ditert-butyl-5-hydroxy-phenyl)-4-oxo-1H-quinoline-3-carboxamide
  • N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide
  • N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
  • N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide
  • N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
  • N-(5-Hydroxy-2,4-bis(2-methyl-2-propanyl)phenyl]-4-oxo-1,4-dihydro-3-quinolinecarboxamide
  • N-(5-Hydroxy-2,4-di-tert-butylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
  • N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
  • N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide
  • N-[2,4-Bis[1,1-di(methyl)ethyl]-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
  • 1134822-00-6
  • 3-Quinolinecarboxamide, N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide; Ivacaftor; Kalydeco; N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide; VX 770
  • 800-027-5
  • Kalydeco|||N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide
  • VX7